Study Evaluating The Tolerability Of Multiple Doses Of HKI-272
NCT00757809
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Subjects
Interventions
DRUG:
neratinib
Sponsor
Puma Biotechnology, Inc.